Mike Crapo actually said...

I have long championed efforts to improve prescription drug access and affordability for all Americans.

When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few different things.

We need to identify avenues for lowering out-of-pocket costs, increasing competition, and promoting access to lifesaving innovation--and we ...

That said, much has changed in the past 2 decades, and we have an obligation both to build on the aspects of Part D that work well and to ad...